Join
Live feed
·
INSIDERFilingvia Quantisnow
Entero Therapeutics Inc. logo

Director Khosla Chaitan Phd was granted 24,889 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ENTO· Entero Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENTO (Entero Therapeutics Inc.) and more on Quantisnow.

Director Khosla Chaitan Phd was granted 24,889 shares (SEC Form 4) | Quantisnow